Wednesday, 28 October 20266:30 pm ISTIndia edition

Just in

6:27 pmDSIIDC's online liquor booking app permitted by previous Delhi government: Officials
6:25 pmBihar MLC polls: Jan Suraaj Party opens account, JD(U)'s Neeraj Kumar 'wins' Patna Graduates seat
6:25 pmKarnataka Council polls: Coordinated efforts helped NDA allies make a clean sweep
6:25 pmNDTV Profit Ignite 2026 Live Updates: Only 9% Companies Invest In Growth, Says Harvard Professor Ranjay Gulati
6:23 pmIsraeli Arab parties hold key as Netanyahu falls short of majority
SponsoredPut your announcement in this ticker from ₹69/day
6:21 pmHassan DC bans vehicles to Male Malleshwara temple at Seegegudda in Hassan
6:20 pmNaidu writes to Amit Shah, seeks Central aid for cyclone damage in Andhra Pradesh
6:20 pmPM Modi taunts Congress for dismal show in MLC polls despite use of paper ballots
6:11 pmWPL 2027 Auction UP Warriorz sign Sophie Molineux for 1.10 Cr; bring back Grace Harris
6:10 pmNirmala Sitharaman rebuts Rahul Gandhi for terming Tata Group dispute ‘criminal’
6:04 pmVeteran civil servant Syed Munir Hoda passes away at 76
6:04 pmSupreme Court summons Sanjay Raut in person, Nikhil Wagle virtually in contempt case on November 17
6:02 pmTelangana offers A.P. help in restoring power supply after Cyclone Arnab
5:45 pmFormer Bengal minister Indranil Sen arrested in Kolkata over alleged financial irregularities in Durga Puja preview shows
6:27 pmDSIIDC's online liquor booking app permitted by previous Delhi government: Officials
6:25 pmBihar MLC polls: Jan Suraaj Party opens account, JD(U)'s Neeraj Kumar 'wins' Patna Graduates seat
6:25 pmKarnataka Council polls: Coordinated efforts helped NDA allies make a clean sweep
6:25 pmNDTV Profit Ignite 2026 Live Updates: Only 9% Companies Invest In Growth, Says Harvard Professor Ranjay Gulati
6:23 pmIsraeli Arab parties hold key as Netanyahu falls short of majority
SponsoredPut your announcement in this ticker from ₹69/day
6:21 pmHassan DC bans vehicles to Male Malleshwara temple at Seegegudda in Hassan
6:20 pmNaidu writes to Amit Shah, seeks Central aid for cyclone damage in Andhra Pradesh
6:20 pmPM Modi taunts Congress for dismal show in MLC polls despite use of paper ballots
6:11 pmWPL 2027 Auction UP Warriorz sign Sophie Molineux for 1.10 Cr; bring back Grace Harris
6:10 pmNirmala Sitharaman rebuts Rahul Gandhi for terming Tata Group dispute ‘criminal’
6:04 pmVeteran civil servant Syed Munir Hoda passes away at 76
6:04 pmSupreme Court summons Sanjay Raut in person, Nikhil Wagle virtually in contempt case on November 17
6:02 pmTelangana offers A.P. help in restoring power supply after Cyclone Arnab
5:45 pmFormer Bengal minister Indranil Sen arrested in Kolkata over alleged financial irregularities in Durga Puja preview shows

Business

Lynk Pharmaceuticals Reports Positive Long-Term Phase III Results for Zemprocitinib in bDMARDs-Inadequate Responders with Moderate-to-Severe Rheumatoid Arthritis

Reported by Pr Newswire Apac 28 Oct 2026, 5:30 am IST 1 min read

Business news on The Headline Update

HANGZHOU, China, SHANGHAI and BOSTON, Oct. 28, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced positive long-term results from its pivotal Phase...

Read the full report on Pr Newswire Apac

Story file

Section: Business
First reported by: Pr Newswire Apac
Reporter: lynk pharmaceuticals co, ltd
Published: Wednesday, 28 October 2026, 5:30 am IST
Coverage: One outlet so far

How this page works. The Headline Update lists this report from Pr Newswire Apac with a short summary and a link to the original. The original reporting belongs to the publisher. Spotted an error in our summary? Tell our corrections desk.